ArticleLeukemia2017
Calreticulin mutant mice develop essential thrombocythemia that is ameliorated by the JAK inhibitor ruxolitinib.
K Shide et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
43 papers cite it
this papercites it
ArticleLeukemia2017
K Shide et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.